Maria Giulia Rizzo
4PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 21, 2025
A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis.Giulia Regazzo, Giulia Vari, Francesco Marchesi
|May 21, 2025
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing.Ana Belén Díaz Méndez, Marta Di Giuliani, Andrea Sacconi
|Jul 28, 2021
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patients.Federica Rinaldi, Francesco Marchesi, Francesca Palombi
|Jan 06, 2021
Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers.Ana Belén Díaz Méndez, Elisa Tremante, Giulia Regazzo
Pageof 1
